Karin Wirdefeldt
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Helicobacter pylori infection, peptic ulcer, gastritis and risk of Parkinson's disease: A nationwide matched cohort study.
Journal: Journal of Parkinson's disease
Published: July 15, 2026
Prescriber adherence to treatment guidelines for monoclonal antibodies against Calcitonin Gene-Related Peptide in migraine prophylaxis - a register-based cohort study.
Journal: The journal of headache and pain
Published: February 03, 2026
Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset.
Journal: NPJ Parkinson's disease
Published: January 20, 2026
Microscopic colitis is associated with an increased risk of dementia in a Swedish population.
Journal: Journal of internal medicine
Published: November 26, 2025
Incidence, Etiology, and Long-Term Outcome of Acute Myelitis in Stockholm County, Sweden: A Population-Based Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: November 03, 2025
Incidence, Etiology, and Long-Term Outcome of Acute Myelitis in Stockholm County, Sweden: A Population-Based Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: September 09, 2025
Genome-wide association study of copy number variations in Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: August 24, 2025
Higher socioeconomic status is associated with dispensation of monoclonal antibodies against calcitonin gene-related peptide in migraine: A nested case-control study.
Journal: Cephalalgia : an international journal of headache
Published: June 18, 2025
Hospital-treated infectious diseases and the risk of epilepsy in older age.
Journal: Nature aging
Published: February 19, 2025
Mediterranean dietary pattern and risk of neurodegenerative diseases in a cohort of Swedish women.
Journal: NPJ Parkinson's disease
Published: January 08, 2025
NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 18, 2024
Last Updated: 09/26/2026